ELAN

ELAN

USD

Elanco Animal Health Incorporated Common Stock

$22.500+0.270 (1.215%)

Цена в режиме реального времени

Healthcare
Drug Manufacturers - Specialty & Generic
Соединенные Штаты

График цен

Loading Chart...

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$22.230

Максимум

$22.840

Минимум

$22.150

Объем

12.80M

Фундаментальные показатели компании

Рыночная капитализация

11.2B

Отрасль

Drug Manufacturers - Specialty & Generic

Страна

United States

Статистические данные торговли

Средний объем

7.18M

Биржа

NYQ

Валюта

USD

52-недельный диапазон

Минимум $8.02Текущая $22.500Максимум $22.96

Связанные новости

PR Newswire

Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species

Elanco Animal Health Incorporated (NYSE: ELAN) today announced label expansions for two of its leading canine prescription parasiticides, Credelio...

Просмотреть больше
Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species
PR Newswire

Elanco's Credelio™ (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs

Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug...

Просмотреть больше
Elanco's Credelio™ (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs
Analyst Upgrades

JP Morgan Upgrades Elanco Animal Health to Overweight, Raises Price Target to $24

JP Morgan analyst Chris Schott upgrades Elanco Animal Health from Neutral to Overweight and raises the price target from $18 to $24.

Просмотреть больше
JP Morgan Upgrades Elanco Animal Health to Overweight, Raises Price Target to $24

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.